Richard Gordon
6PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|May 17, 2023
Response to Comment on "Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice".Eduardo A Albornoz, Richard Gordon, Vinod Kumar
|Mar 15, 2023
A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic Inflammation.Nanthini Jayabalan, Bryan Oronsky, Pedro Cabrales
|Nov 02, 2018
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice.Richard Gordon, Eduardo A Albornoz, Daniel C Christie
|Mar 02, 2018
An overview of sleep and circadian dysfunction in Parkinson's disease.Susanna Mantovani, Simon S Smith, Richard Gordon
|Aug 25, 2017
The Ketone Body β-Hydroxybutyrate Does Not Inhibit Synuclein Mediated Inflammasome Activation in Microglia.Vandana Deora, Eduardo A Albornoz, Kevin Zhu
|Oct 06, 2016
Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration.Richard Gordon, Matthew L Neal, Jie Luo
Pageof 1
Frequent Collaborators
2 joint publications
Trent M Woodruff
2 joint publications
Susanna Mantovani
2 joint publications
Eduardo A Albornoz
2 joint publications
Vinod Kumar
2 joint publications
Avril A B Robertson
2 joint publications
Kate Schroder
1 joint publications
Dilshan S Harischandra
1 joint publications
Simon S Smith
1 joint publications
Daniel C Christie
1 joint publications
Monica R Langley
